Inspira Technologies Signs Term Sheet for Organ Transplant Device Use
Ticker: IINNW · Form: 6-K · Filed: Apr 17, 2024 · CIK: 1837493
Sentiment: bullish
Topics: medical-device, organ-transplant, term-sheet, commercialization
TL;DR
Inspira signs deal to use ART100 device in organ transplants - big step for their tech!
AI Summary
Inspira Technologies Oxy B.H.N. Ltd. announced on April 16, 2024, that it has signed a term sheet for the use of its INSPIRA ART100 device in organ transplant procedures. This agreement signifies a step towards the potential commercialization and application of their technology in a critical medical field.
Why It Matters
This term sheet could pave the way for the INSPIRA ART100 device to be used in life-saving organ transplant surgeries, potentially improving outcomes and expanding the availability of transplants.
Risk Assessment
Risk Level: medium — The filing is a term sheet, indicating preliminary agreement rather than a finalized contract, and commercialization is still subject to further development and regulatory approvals.
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — Registrant
- INSPIRA ART100 (product) — Device for organ transplant procedures
- April 16, 2024 (date) — Date of press release and term sheet signing
FAQ
What is the specific nature of the term sheet signed by Inspira Technologies?
Inspira Technologies signed a term sheet for the use of its INSPIRA ART100 device in organ transplant procedures.
When was this term sheet announced?
The term sheet was announced on April 16, 2024.
What is the name of the device mentioned in the filing?
The device mentioned is the INSPIRA ART100.
What type of medical procedures is the INSPIRA ART100 device intended for?
The INSPIRA ART100 device is intended for use in organ transplant procedures.
What form was filed with the SEC regarding this announcement?
A Form 6-K was filed with the SEC, furnishing a press release as Exhibit 99.1.
Filing Stats: 304 words · 1 min read · ~1 pages · Grade level 8.5 · Accepted 2024-04-17 06:43:07
Filing Documents
- ea0204064-6k_inspira.htm (6-K) — 12KB
- ea020406401ex99-1_inspira.htm (EX-99.1) — 13KB
- 0001213900-24-033583.txt ( ) — 26KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: April 17, 2024 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2